Philadelphia, Pennsylvania 19104


Purpose:

The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to increase uptake of genetic testing and identification of genetic carriers compared to usual care. Secondly, we will evaluate the advantages of videoconferencing over telephone for delivery of remote genetic services and the short-term and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients in community practices.


Criteria:

Inclusion Criteria: 1. Eligible participants will include adult men and women (aged 18 and older) who can understand and communicate in English 2. meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian or colorectal cancers 3. have insurance coverage for genetic testing. Exclusion Criteria: 1. Under 18 years old - professional guidelines do not recommend genetic testing for cancer risk in minors. 2. Does not speak English. 3. Does not have insurance.


NCT ID:

NCT02517554


Primary Contact:

Principal Investigator
Angela Bradbury, MD
Abramson Cancer Center of the University of Pennsylvania

Angela Bradbury, MD
Phone: 855-216-0098
Email: PennCancerTrials@emergingmed.com


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19104
United States

Angela Bradbury, MD
Phone: 855-216-0098
Email: PennCancerTrials@emergingmed.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 21, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.